Skip to main content
. Author manuscript; available in PMC: 2021 Aug 5.
Published in final edited form as: Mol Pharm. 2015 Jun 9;12(7):2544–2550. doi: 10.1021/acs.molpharmaceut.5b00257

Figure 1.

Figure 1.

Structure of legumain and αvβ3 integrin inhibitors, the antibody programming agents, and chemically programmed antibodies. Compounds 35 reacted with Ab 38C2 at 37 °C for 2–24 h affording anti-legumain, anti-integrin cpAbs (38C2-3, 38C2-4) and cp-bsAb (38C2-5). Compound [4a] is an intermediate produced by an in situ retro aldol reaction of compound 4 before the latter reacts with the Ab. Key: legumain and integrin inhibitors are portrayed in green and blue, respectively.